학술논문

IMMUNOGENICITY INDUCED BY THE ACADEMIC CHIMERIC ANTIGEN RECEPTOR CAR19 (ARI-0001) IN PATIENTS WITH CD19-POSITIVE RELAPSED/REFRACTORY B-CELL MALIGNANCIES RECRUITED INTO THE CART19BE-01 CLINICAL TRIAL
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; OCT 2020, 8 pA54-pA54, 1p. Supplement: 2
Subject
Language
English
ISSN
20511426